Resveratrol and Spirulina: Nutraceuticals that Potentially Improving Cardiovascular Disease
Article Sidebar
Main Article Content
Abstract
Resveratrol (3,5,4’-trihydroxy-trans-stilbene) is an extensively studied nutraceutical with several proposed health benefits, including cardio protection, antimetabolic syndrome, and antiatherogenic effects. It was brought to popularity through the proposed “French Paradox” and the consumption of red wine. It has been shown to down regulate the activation of numerous inflammatory and oxidative stress markers with therapeutic potentials. Spirulina (Arthrospira platensis), on the other hand, is a highly nutritional nutraceutical that has not been sufficiently studied. However, several in vitro and animal studies point to its hypolipidemic and antihypertensive properties, which are similar to resveratrol. Although resveratrol and Spirulina both constitutes functional foods with potential therapeutic effects on several cardiovascular diseases, there are few compelling clinical evidence to support their applications in human patients. This warrant further evaluation in clinical trials. This article reviews and evaluates the beneficial effects of the two different nutraceuticals in order to demonstrate their potential in clinical application in patients with cardiovascular diseases.
Downloads
Article Details
Copyright (c) 2020 Wang Y, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Heart Disease Facts (2019) Centers for Disease Control and Prevention. Link: https://bit.ly/36qY7UI
Coronary Artery Disease (2019) Centers for Disease Control and Prevention. Link: https://bit.ly/3cWgGCZ
Gambini J, López-Grueso R, Olaso-González G, Inglés M, Abdelazid K, et al. (2013) Resveratrol: distribution, properties and perspectives. Rev Esp Geriatr Gerontol 48: 79-88. Link: https://bit.ly/36mkGKv
Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526. Link: https://bit.ly/2A6U5EU
Karkos PD, Leong SC, Karkos CD, Sivaji N, Assimakpoulos DA (2011) Spirulina in Clinical Practice: Evidence-Based Human Applications. Evid Based Complement Alternat Med 2011. Link: https://bit.ly/3ghZSIH
Wu Q, Liu L, Miron A, Klímová B, Wan D, et al. (2016) The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview. Arch. Toxicol 90: 1817-1840. Link: https://bit.ly/2Zux3mk
Lietstianty D, Rodianawati I, Arfah RA, Assa A, Patimah et al. (2019) Nutritional Analysis of Spirulina sp. to Promote as Superfood Candidate. Materials Science and Engineering 1-6. Link: https://bit.ly/3ghJV52
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al. (2004) Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 24: 2783-2840. Link: https://bit.ly/3easTUI
Stervbo U, Vang O, Bonnesen C (2007) A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem 101: 449-457. Link: https://bit.ly/3eeHy0W
Fornara V, Onelli E, Sparvoli F, Rossoni M, Aina R, et al. (2008) Localization of stilbene synthase in Vitis vinifera L. during berry development. Protoplasma 233: 83-93. Link: https://bit.ly/2yw3QMK
Trela BC, Waterhouse AL (1996) Resveratrol: Isomeric molar absorptivities and stability. J Agric Food Chem 44: 1253-1257. Link: https://bit.ly/2Tv96Yj
Khan MA, Muzammil S, Musarrat J (2002) Differential binding of tetracyclines with serum albumin and induced structural alterations in drugbound protein. Int J Biol Macromol 30: 243-249. Link: https://bit.ly/2AORK1S
Jannin B, Menzel M, Berlot JP, Delmas D, Lancon A, et al. (2004) Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol 68: 1113-1118. Link: https://bit.ly/3cZxiJV
Juhasz B, Mukherjee S, Das DK (2010) Hormetic response of resveratrol against cardioprotection. Exp Clin Cardiol 15: e134-e138. Link: https://bit.ly/2LRzPtJ
Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, et al. (2018) Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines 6: 91. Link: https://bit.ly/2zd8AHv
Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, et al. (2002) Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302: 369-373. Link: https://bit.ly/2TyWz5U
Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32: 1377-1382. Link: https://bit.ly/2LW3cuM
Boocock DJ, Patel KR, Faust GES, Normolle DP, Marczylo TH, et al. (2007) Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B 848: 182-187. Link: https://bit.ly/2WV4ht7
Piver B, Berthou F, Dreano Y, Lucas D (2001) Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol Lett 125: 83-91. Link: https://bit.ly/2AVQpXh
Kaldas MI, Walle UK, Walle T (2003) Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol 55: 307-312. Link: https://bit.ly/2XmW007
Caddeo C, Teskac K, Sinico C, Kristl J (2008) Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm 363: 183-191. Link: https://bit.ly/3gg4Sxh
Coimbra M, Isacchi B, van Bloois L, Torano JS, Ket A, et al. (2011) Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int J Pharm 416: 433-442. Link: https://bit.ly/3bW85if
Teskac K., Kristl J (2010) The evidence for solid-lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm 390: 61-69. Link: https://bit.ly/2TxyWux
Das S, Ng KY (2009) Resveratrol-Loaded Calcium-Pectinate Beads: Effects of Formulation Parameters on Drug Release and Bead Characteristics. J Pharm Sci 99: 840-860. Link: https://bit.ly/2ZwxDQq
Das S, Ng KY, Ho PC (2010) Formulation and optimization of zinc-pectinate beads for the controlled delivery of resveratrol. AAPS Pharm Sci Tech 11: 729-724. Link: https://bit.ly/2LTzlDC
Qing-Shan Li, Yao Li, Deora GS, Ruan BF (2019) Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification. Mini Rev Med Chem 19: 809-825. Link: https://bit.ly/2Xm1tob
Wang P, Sang S (2018) Metabolism and pharmacokinetics of resveratrol and pterostilbene. Biofactors 44: 16–25. Link: https://bit.ly/2XmV1Nt
Nawaz W, Zhou Z, Deng S, Ma X, Ma X, et al. (2017) Therapeutic Versatility of Resveratrol Derivatives. Nutrients 9: 1188. Link: https://bit.ly/3bYhCFk
Park WS, Kim HJ, Li M, Lim DH, Kim J, et al. (2018) Two Classes of Pigments, Carotenoids and C-Phycocyanin, in Spirulina Powder and Their Antioxidant Activities. Molecules 23: 2065. Link: https://bit.ly/3gfIzbe
Romay Ch, González R, Ledón N, Remirez D, Rimbau V (2003) C--phycocyanin: A Biliprotein with Antioxidant, Anti-Inflammatory and Neuroprotective Effects. Curr Protein Pept Sci 4: 207-216. Link: https://bit.ly/2ZtySQk
Sticova E, Jirsa M (2013) New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol 19: 6398-6407. Link: https://bit.ly/2zd12o9
Liwa AC, Barton EN, Cole WC (2017) Bioactive Plant Molecules, Sources and Mechanism of Action in the Treatment of Cardiovascular Disease. Pharmacognosy Fundamentals, Applications and Strategies 315-336
Shete V, Quadro L (2013) Mammalian metabolism of β-carotene: gaps in knowledge. Nutrients 5: 4849-4868. Link: https://bit.ly/2Zxjjai
Morais M, Vaz B, Morais E, Costa J (2014) Biological Effects of Spirulina (Arthrospira) Biopolymers and Biomass in the Development of Nanostructured Scaffolds. BioMed Research International 1-9. Link: https://bit.ly/2yqomOE
Ross R (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340: 115-126. Link: https://bit.ly/3ghNKXR
Atherosclerotic Cardiovascular Disease (1989) National Research Council (US) Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington (DC): the National Academies Press (US).
Koushki M, Dashatan NA, Meshkani R (2018) Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin Ther 40: 1180-1192. Link: https://bit.ly/2ZBzhjA
Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, et al. (2012) Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc 50: 179-187. Link: https://bit.ly/3e9ofGs
Chow SE, Hshu YC, Wang JS, Chen JK (1985) Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol 102: 1520-1527. Link: https://bit.ly/2XrhuJi
Bradamante S, Barenghi L, Piccinini F, Bertelli AAE, Jonge RD, et al. (2003) Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Pharmacol 465: 115-123. Link: https://bit.ly/2WUs24z
Zhang H, Zhang J, Ungvari Z, Zhang C (2009) Resveratrol improves endothelial function: Role of TNFa and vascular oxidative stress. Arterioscler Thromb Vasc Biol 29: 1164–1171. Link: https://bit.ly/2LUnZyV
Hoffmann J, Haendeler J, Aicher A, Rössig L, Vasa M, et al. (2001) Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: Important role of nitric oxide. Circ Res 89: 709-715. Link: https://bit.ly/3bQ9V4c
Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, et al. (2002) Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 90: 1159-1166. Link: https://bit.ly/3easT6Z
O’Leary KA, de Pascual-Teresa S, Needs PW, Bao YP, O’Brien NM, et al. (2004) Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 551: 245–254. Link: https://bit.ly/2TwGSfG
Chao HH, Juan SH, Liu JC, Yang YH, Yang E, et al. (2005) Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. Eur J Pharmacol 515: 1-9. Link: https://bit.ly/2AUMh9W
Yang B, Ma S, Wang YB, Xu B, Zhao H, et al. (2016) Resveratrol exerts protective effects on anoxia/reoxygenation injury in cardiomyocytes via miR-34a/Sirt1 signaling pathway. Eur Rev Med Pharmacol Sci 20: 2734-2741. Link: https://bit.ly/2AMbKSL
Deng R, Chow TJ (2010) Hypolipidemic, antioxidant, and anti-inflammatory activities of microalgae Spirulina. Cardiovasc Ther 28: e33-e45. Link: https://bit.ly/2AMbC5J
Ku CS, Pham TX, Park Y, Kim B, Shin MS, et al. (2013) Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes. Biochim Biophys Acta 1830: 2981-2988. Link: https://bit.ly/36qPZDG
Agarwal B, Campen MJ, Channell MM, Wherry SJ, Varamini B, et al. (2013) Resveratrol for primary prevention of atherosclerosis: Clinical trial evidence for improved gene expression in vascular endothelium. Int J Cardiol 166: 246–248. Link: https://bit.ly/2LOIv42
Militaru C, Donoiu I, Craciun A, Scorei ID, Bulearca AM, et al. (2013) Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life. Nutrition 29: 178-183. Link: https://bit.ly/2WVkm23
Movahed A, Nabipour I, Lieben Louis X, Thandapilly SJ, Yu L, et al. (2013) Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid Based Complement Alternat Med 2013: 11. Link: https://bit.ly/3e9mM2U
Martínez-Sámano J, Torres-Montes de Oca A, Luqueño-Bocardo OI, Torres-Durán PV, Juárez-Oropeza MA (2018) Spirulina maxima Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial. Mar Drugs 16: 496. Link: https://bit.ly/2ywwgWY
Torres-Duran PV, Ferreira-Hermosillo A, Juarez-Oropeza MA (2007) Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report. Lipids Health Dis 6: 33. Link: https://bit.ly/2AS3AIB
Cheong S, Kim M, Sok D, Hwang S, Kim J, et al. (2010) Spirulina Prevents Atherosclerosis by Reducing Hypercholesterolemia in Rabbits Fed a High-Cholesterol Diet. J Nutr Sci Vitaminol 56: 34-40. Link: https://bit.ly/2AULiXi
Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, et al. (2013) High-dose resveratrol supplementation in obese men: An investigatorinitiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62: 1186-1195. Link: https://bit.ly/3ga16pj
Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, et al. (2012) Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67: 1307–1312. Link: https://bit.ly/36nHlpL
Resveratrol Dose By The Annals of the New York Academy of Sciences. Rev Genetics. Link: https://bit.ly/2yoP762
Burns J, Yokota T, Ashihara H, Lean ME, Crozier A (2002) Plant foods and herbal sources of resveratrol. J Agric Food Chem 50: 3337-3340. Link: https://bit.ly/3bX0XlI
Stervbo U, Vang O, Bonnesen C (2007) A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem 101: 449–457. Link: https://bit.ly/3eeHy0W
Joventino IP, Alves HGR, Neves NC, Pinheiro-Joventino F, Leal LKAM et al. (2012) The microalga Spirulina platensis presents anti-inflammatory action as well as hypoglycemic and hypolipidemic properties in diabetic rats. J Complement Integr Med 9. Link: https://bit.ly/3c0EqEp
Miczke A, Szulińska M, Hansdorfer-Korzon R, Kręgielska-Narożna M, Suliburska J, et al. (2016) Effects of Spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians: a double-blind, placebo-controlled, randomized trial. Eur Rev Med Pharmacol Sci 20: 150-156. Link: https://bit.ly/2Twohk1
Cho S, Namkoong K, Shin M, Park J, Yang E, et al. (2017) Cardiovascular Protective Effects and Clinical Applications of Resveratrol. J Med Food 20: 323–334. Link: https://bit.ly/3bZugnA
Jeong SJ, Choi JW, Lee MK, Choi YH, Nam TJ (2019) Spirulina Crude Protein Promotes the Migration and Proliferation in IEC-6 Cells by Activating EGFR/MAPK Signaling Pathway. Mar Drugs 17: 205. Link: https://bit.ly/2A4z9hS